These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25272965)

  • 1. An examination of the bidirectional relationship between functioning and symptom levels in patients with anxiety disorders in the CALM study.
    Brown LA; Krull JL; Roy-Byrne P; Sherbourne CD; Stein MB; Sullivan G; Rose RD; Bystritsky A; Craske MG
    Psychol Med; 2015 Feb; 45(3):647-61. PubMed ID: 25272965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic subgroups for remission and response in the Coordinated Anxiety Learning and Management (CALM) trial.
    Kelly JM; Jakubovski E; Bloch MH
    J Clin Psychiatry; 2015 Mar; 76(3):267-78. PubMed ID: 25562579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anxiety treatment improves physical functioning with oblique scoring of the SF-12 short form health survey.
    Niles AN; Sherbourne CD; Roy-Byrne PP; Stein MB; Sullivan G; Bystritsky A; Craske MG
    Gen Hosp Psychiatry; 2013; 35(3):291-6. PubMed ID: 23332608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of co-occurring depression on treatment for anxiety disorders: analysis of outcomes from a large primary care effectiveness trial.
    Campbell-Sills L; Sherbourne CD; Roy-Byrne P; Craske MG; Sullivan G; Bystritsky A; Lang AJ; Chavira DA; Rose RD; Shaw Welch S; Stein MB
    J Clin Psychiatry; 2012 Dec; 73(12):1509-16. PubMed ID: 23290323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disorder-specific impact of coordinated anxiety learning and management treatment for anxiety disorders in primary care.
    Craske MG; Stein MB; Sullivan G; Sherbourne C; Bystritsky A; Rose RD; Lang AJ; Welch S; Campbell-Sills L; Golinelli D; Roy-Byrne P
    Arch Gen Psychiatry; 2011 Apr; 68(4):378-88. PubMed ID: 21464362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incremental benefits and cost of coordinated anxiety learning and management for anxiety treatment in primary care.
    Joesch JM; Sherbourne CD; Sullivan G; Stein MB; Craske MG; Roy-Byrne P
    Psychol Med; 2012 Sep; 42(9):1937-48. PubMed ID: 22152230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in self-efficacy and outcome expectancy as predictors of anxiety outcomes from the CALM study.
    Brown LA; Wiley JF; Wolitzky-Taylor K; Roy-Byrne P; Sherbourne C; Stein MB; Sullivan G; Rose RD; Bystritsky A; Craske MG
    Depress Anxiety; 2014 Aug; 31(8):678-89. PubMed ID: 24619599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivery of evidence-based treatment for multiple anxiety disorders in primary care: a randomized controlled trial.
    Roy-Byrne P; Craske MG; Sullivan G; Rose RD; Edlund MJ; Lang AJ; Bystritsky A; Welch SS; Chavira DA; Golinelli D; Campbell-Sills L; Sherbourne CD; Stein MB
    JAMA; 2010 May; 303(19):1921-8. PubMed ID: 20483968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of alcohol use severity on anxiety treatment outcomes in a large effectiveness trial in primary care.
    Wolitzky-Taylor K; Brown LA; Roy-Byrne P; Sherbourne C; Stein MB; Sullivan G; Bystritsky A; Craske MG
    J Anxiety Disord; 2015 Mar; 30():88-93. PubMed ID: 25615523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Who needs more than standard care? Treatment moderators in a randomized clinical trial comparing addiction treatment alone to addiction treatment plus anxiety disorder treatment for comorbid anxiety and substance use disorders.
    Wolitzky-Taylor K; Niles AN; Ries R; Krull JL; Rawson R; Roy-Byrne P; Craske M
    Behav Res Ther; 2018 Aug; 107():1-9. PubMed ID: 29800622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naturalistic follow-up of youths treated for pediatric anxiety disorders.
    Ginsburg GS; Becker EM; Keeton CP; Sakolsky D; Piacentini J; Albano AM; Compton SN; Iyengar S; Sullivan K; Caporino N; Peris T; Birmaher B; Rynn M; March J; Kendall PC
    JAMA Psychiatry; 2014 Mar; 71(3):310-8. PubMed ID: 24477837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trajectories of change in anxiety severity and impairment during and after treatment with evidence-based treatment for multiple anxiety disorders in primary care.
    Joesch JM; Golinelli D; Sherbourne CD; Sullivan G; Stein MB; Craske MG; Roy-Byrne PP
    Depress Anxiety; 2013 Nov; 30(11):1099-106. PubMed ID: 23801589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.
    Leaviss J; Davis S; Ren S; Hamilton J; Scope A; Booth A; Sutton A; Parry G; Buszewicz M; Moss-Morris R; White P
    Health Technol Assess; 2020 Sep; 24(46):1-490. PubMed ID: 32975190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving outcomes for patients with medication-resistant anxiety: effects of collaborative care with cognitive behavioral therapy.
    Campbell-Sills L; Roy-Byrne PP; Craske MG; Bystritsky A; Sullivan G; Stein MB
    Depress Anxiety; 2016 Dec; 33(12):1099-1106. PubMed ID: 27775823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Who gets the most out of cognitive behavioral therapy for anxiety disorders? The role of treatment dose and patient engagement.
    Glenn D; Golinelli D; Rose RD; Roy-Byrne P; Stein MB; Sullivan G; Bystritksy A; Sherbourne C; Craske MG
    J Consult Clin Psychol; 2013 Aug; 81(4):639-649. PubMed ID: 23750465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized clinical trial evaluating the preliminary effectiveness of an integrated anxiety disorder treatment in substance use disorder specialty clinics.
    Wolitzky-Taylor K; Krull J; Rawson R; Roy-Byrne P; Ries R; Craske MG
    J Consult Clin Psychol; 2018 Jan; 86(1):81-88. PubMed ID: 29300100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perceived social support mediates anxiety and depressive symptom changes following primary care intervention.
    Dour HJ; Wiley JF; Roy-Byrne P; Stein MB; Sullivan G; Sherbourne CD; Bystritsky A; Rose RD; Craske MG
    Depress Anxiety; 2014 May; 31(5):436-42. PubMed ID: 24338947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age differences in treatment response to a collaborative care intervention for anxiety disorders.
    Wetherell JL; Petkus AJ; Thorp SR; Stein MB; Chavira DA; Campbell-Sills L; Craske MG; Sherbourne C; Bystritsky A; Sullivan G; Roy-Byrne P
    Br J Psychiatry; 2013 Jul; 203(1):65-72. PubMed ID: 23580378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective relations between anxiety sensitivity and transdiagnostic anxiety following cognitive-behavioral therapy: Evidence from the Coordinated Anxiety Learning management trial.
    Hunt C; Campbell-Sills L; Chavira D; Craske M; Sherbourne C; Sullivan G; Roy-Byrne P; Stein MB; Bomyea J
    Behav Res Ther; 2022 Aug; 155():104119. PubMed ID: 35640310
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.